SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

10 Aug 2022 Evaluate
The sales is pegged at Rs. 260.90 millions for the June 2022 quarter. The mentioned figure indicates a decline of about -57.12% as against Rs. 608.40 millions during the year-ago period.The company reported a drastic decline of -83.89% in the quarter ended June 2022 to Rs. 12.50  millions from Rs. 77.60 millions  .The company reported a degrowth in operating Profit to 34.70 millions from 124.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 260.90 608.40 -57.12 260.90 608.40 -57.12 2120.10 2036.70 4.09
Other Income 15.40 17.60 -12.50 15.40 17.60 -12.50 77.80 86.70 -10.27
PBIDT 34.70 124.60 -72.15 34.70 124.60 -72.15 359.20 338.10 6.24
Interest 2.50 2.90 -13.79 2.50 2.90 -13.79 8.90 7.60 17.11
PBDT 32.20 121.70 -73.54 32.20 121.70 -73.54 350.30 330.50 5.99
Depreciation 15.40 17.40 -11.49 15.40 17.40 -11.49 66.60 60.30 10.45
PBT 16.80 104.30 -83.89 16.80 104.30 -83.89 283.70 270.20 5.00
TAX 4.30 26.70 -83.90 4.30 26.70 -83.90 70.70 68.10 3.82
Deferred Tax -0.60 -1.30 -53.85 -0.60 -1.30 -53.85 -9.40 -2.80 235.71
PAT 12.50 77.60 -83.89 12.50 77.60 -83.89 213.00 202.10 5.39
Equity 57.70 57.30 0.70 57.70 57.30 0.70 57.70 57.30 0.70
PBIDTM(%) 13.30 20.48 -35.06 13.30 20.48 -35.06 16.94 16.60 2.06

Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×